MCMedicalCodingSoftware
Free trial
3E0F70M

3E0F70M — Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce of Antneo, Moncln Ab, into Resp Tract, Via Opening

How 3E0F70M is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. FBody partThe specific site
  5. 7ApproachHow the site was reached
  6. 0DeviceWhat was left in place, if anything
  7. MQualifierA further distinction where one applies

Codes near 3E0F70M

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0F3KZIntroduction of Other Diagnostic Substance into Respiratory Tract, Percutaneous Approach
  • 3E0F3NZIntroduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Percutaneous Approach
  • 3E0F3SDIntroduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach
  • 3E0F3SFIntroduction of Other Gas into Respiratory Tract, Percutaneous Approach
  • 3E0F3TZIntroduction of Destructive Agent into Respiratory Tract, Percutaneous Approach
  • 3E0F4GCIntroduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Endoscopic Approach
  • 3E0F704Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F705Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F70MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F728Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F729Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F73ZIntroduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F76ZIntroduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F77ZIntroduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F7BZIntroduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F7GCIntroduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F7HZIntroduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening
ICD-10-PCSFY2026